Company
Headquarters: Changsha, China
Employees: 22,808
CN¥131.14 Billion
CNY as of Jan. 1, 2025
US$17.97 Billion
Company | Market Cap (USD) |
---|---|
Lilly | $689.42 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $487.54 B |
Johnson & Johnson | $353.05 B |
AbbVie | $301.60 B |
Aier Eye Hospital Group Co., Ltd. operates eye care hospitals and institutions. The company offers medical services in the areas of fundus diseases, optometry, refractive correction, glaucoma, corneal diseases, and cataract. It also provides training course for cataract prevention and treatment. The company operates approximately 500 ophthalmic hospitals in mainland China, 86 ophthalmic hospitals in Europe, 1 ophthalmic hospital in the United States, 7 ophthalmic hospitals in Hong Kong, and 12 ophthalmic hospitals in Southeast Asia. The company was founded in 2007 and is headquartered in Changsha, China.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Last Financial Reports Date | Sept. 30, 2024 |
Revenue TTM | CN¥20.62 B |
EBITDA | CN¥5.18 B |
Gross Profit TTM | CN¥10.35 B |
Profit Margin | 17.60% |
Operating Margin | 28.66% |
Quarterly Revenue Growth | -0.70% |
Aier Eye Hospital Group Co. Ltd has the following listings and related stock indices.
Stock: SZSE: 300015 wb_incandescent